Blackstone Group in $3.3bn pharmaceutical deal

Adding to its global pharmaceutical platform, the private equity giant has agreed to buy Ohio-based Pharmaceutical Technologies and Services.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this